Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 46 positions · Total reported value $1.93B · Top-10 concentration 60.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Cormorant Asset Management, LP disclosed 46 equity positions with a combined reported value of $1.93B. The filing implies a focused portfolio: its ten largest positions account for 60.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were PRAX ($285.30M), BBOT ($160.01M), EYPT ($106.54M). By sector, the heaviest allocations are Health Care 89.9%, Industrials 5.5%. Versus the prior quarter, allocation shifted toward Health Care (+17.5pp), Financials (+0.7pp) and away from Industrials (-1.5pp), Other (-16.7pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 56% of names.

The largest new positions opened in Q1 2026 were ERAS ($93.84M), DNTH ($79.72M), DMRA ($39.50M).

Of the 2 positions fully exited versus the prior quarter, the largest were QQQ ($153.58M), IWM ($123.08M), XBI ($121.93M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • ERAS ERASCA INC · $93.84M
  • DNTH DIANTHUS THERAPEUTICS INC · $79.72M
  • DMRA DAMORA THERAPEUTICS INC · $39.50M
  • TNGX TANGO THERAPEUTICS INC · $29.81M
  • AGMB AGOMAB THERAPEUTICS NV · $25.86M
  • MAZE MAZE THERAPEUTICS INC · $22.39M
  • ROIV ROIVANT SCIENCES LTD · $20.77M
  • ANL ADLAI NORTYE GROUP LTD · $20.05M

Fully Exited (vs previous quarter)

  • QQQ INVESCO QQQ TR · prev qtr: $153.58M
  • IWM ISHARES TR · prev qtr: $123.08M
  • XBI SPDR SERIES TRUST · prev qtr: $121.93M
  • ENGN ENGENE THERAPEUTICS INC · prev qtr: $36.12M
  • GHRS GH RESEARCH PLC · prev qtr: $16.51M
  • JANX JANUX THERAPEUTICS INC · prev qtr: $8.97M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 89.9%
Financials 0.7%
Other 3.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 885.50K $285.30M 14.76%
14.76%
Reduce
2 17.88M $160.01M 8.28%
8.28%
Hold
3 8.27M $106.54M 5.51%
5.51%
Hold
4 3.26M $102.69M 5.31%
5.31%
Reduce
5 5.80M $93.84M 4.86%
4.86%
New
6 2.96M $92.54M 4.79%
4.79%
Reduce
7 3.95M $87.00M 4.50%
4.50%
Add
8 760.00K $84.63M 4.38%
4.38%
Reduce
9 4.48M $83.52M 4.32%
4.32%
Add
10 950.00K $79.72M 4.12%
4.12%
New
11 1.06M $77.30M 4.00%
4.00%
Hold
12 850.00K $63.12M 3.27%
3.27%
Reduce
13 2.89M $50.56M 2.62%
2.62%
Add
14 1.05M $41.71M 2.16%
2.16%
Reduce
15 1.52M $39.50M 2.04%
2.04%
New
16 1.12M $33.43M 1.73%
1.73%
Hold
17 190.00K $31.07M 1.61%
1.61%
Reduce
18 950.00K $30.41M 1.57%
1.57%
Reduce
19 1.43M $29.81M 1.54%
1.54%
New
20 1.00M $28.25M 1.46%
1.46%
Reduce
21 533.34K $26.16M 1.35%
1.35%
Hold
22 2.47M $25.86M 1.34%
1.34%
New
23 750.00K $22.39M 1.16%
1.16%
New
24 2.34M $22.02M 1.14%
Form 4 · 1 →
1.14%
Hold
25 95.00K $21.73M 1.12%
1.12%
Reduce
26 750.00K $20.77M 1.07%
1.07%
New
27 2.90M $20.05M 1.04%
1.04%
New
28 300.00K $15.82M 0.82%
0.82%
New
29 225.00K $15.78M 0.82%
0.82%
Reduce
30 1.76M $14.89M 0.77%
0.77%
Add
31 5.50M $14.79M 0.77%
0.77%
Add
32 1.30M $13.18M 0.68%
0.68%
New
33 450.00K $10.60M 0.55%
0.55%
Reduce
34 306.22K $9.65M 0.50%
0.50%
New
35 250.00K $9.08M 0.47%
0.47%
Reduce
36 1.45M $8.63M 0.45%
0.45%
New
37 50.00K $8.45M 0.44%
0.44%
Reduce
38 175.00K $8.44M 0.44%
0.44%
New
39 200.00K $7.70M 0.40%
0.40%
Reduce
40 500.00K $7.46M 0.39%
0.39%
Reduce
41 400.00K $6.58M 0.34%
0.34%
New
42 100.00K $6.27M 0.32%
0.32%
New
43 100.00K $5.81M 0.30%
0.30%
Reduce
44 350.00K $4.87M 0.25%
0.25%
Reduce
45 400.00K $3.59M 0.19%
0.19%
New
46 529.55K $1.39M 0.07%
0.07%
New

FAQ

What did Cormorant Asset Management, LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Cormorant Asset Management, LP reported 46 equity positions worth $1.93B in aggregate; its largest disclosed positions were PRAX ($285.30M), BBOT ($160.01M), EYPT ($106.54M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $1.93B of long equity holdings across 46 positions as of 2026-Q1. Top-10 holdings account for 60.8% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →